Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation

François Faitot, Marc‐Antoine Allard, Gabriella Pittau, Oriana Ciacio, René Adam, Denis Castaing, Antonio Sa Cunha, Gilles Pelletier, Daniel Cherqui, Didier Samuel, Eric Vibert – 24 April 2015 – Liver transplantation (LT) is the best curative treatment for early hepatocellular carcinoma (HCC) in patients with cirrhosis. However, the current shortage of organs causes prolonged waiting times and poorer intention‐to‐treat (ITT) survival (i.e., after listing) owing to tumor progression and dropout.

Myeloid cells in hepatocellular carcinoma

Shanshan Wan, Ning Kuo, Ilona Kryczek, Weiping Zou, Theodore H. Welling – 24 April 2015 – Hepatocellular carcinoma (HCC) is highly associated with inflammation. Myeloid cells, including tumor‐associated macrophages and myeloid‐derived suppressor cells, are abundant in the HCC microenvironment and are often associated with poor prognosis. Myeloid cells in HCC play a vital role in supporting tumor initiation, progression, angiogenesis, metastasis, and therapeutic resistance.

Reply

Mathieu Sertorio, Rodrigo F. Carmo, Sandrine Cabantous, Luydson Vasconcelos, Leila Beltrao Pereira, Patricia Moura, Alain Dessein – 23 April 2015

Reply

Christine E. McLaren, Mary J. Emond, V. Nathan Subramaniam, Pradyumna D. Phatak, James C. Barton, Paul C. Adams, Lawrie W. Powell, Lyle C. Gurrin, Grant A. Ramm, Gregory J. Anderson, Gordon D. McLaren – 23 April 2015

Presentation, diagnosis, and management of early hepatic venous outflow complications in whole cadaveric liver transplant

Shirin Elizabeth Khorsandi, Anuja Athale, Hector Vilca‐Melendez, Wayel Jassem, Andreas Prachalias, Parthi Srinivasan, Mohamed Rela, Nigel Heaton – 23 April 2015 – Early hepatic venous outflow obstruction (HVOO) can be a devastating complication leading to graft loss after liver transplantation (LT).

Subscribe to